Markers of oxidative protein damage in plasma and urine of type 2 diabetic patients

British Journal of Biomedical Science

Volumn 66, Issue 4, 2009, Pages 194-199

  Piwowar, Agnieszka ^a   Knapik Kordecka, M ^a   Warwas, M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Diabetes mellitus, type 2; Nephropathy; Oxidative damage; Plasma; Urine

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; CARBONYL DERIVATIVE; THYROTROPIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SPECTROPHOTOMETRY;

EID: 75649103982     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2009.11730273     Document Type: Article

References (36)

1. Pennathur S, Heinecke JW Mechanisms of oxidative stress in diabetes: implications for the pathogenesis of vascular disease and antioxidant therapy. Front Biosci 2004; 9: 565-74.
2. Son SM. Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes. Diabetes Res Clin Pract 2O07; 77 (Suppl 1): S65-70.
3. Maiese K, Morhan SD, Chong ZZ. Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res 2007; 4: 63-71.
4. Ramakrishna V Jailkhani R. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 2008; 45: 41-6.
5. Choi SW, Benzie IF, Ma SW et al. Acute hyperglycaemia and oxidative stress: direct cause and effect? Free Radic Biol Med 2008; 44: 1217-31.
6. Abou-Seif AM, Youssef AA. Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 2004; 346: 161-70.
7. Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag 2007; 3: 853-76.
8. Robertson RP Harmon J, Tran POT et al. Beta-cell glucose toxicity, lipotoxicity and chronic oxidative stress in type 2 diabetes. Diabetes 2004; 53 (Suppl 1): S119-24.
9. Dalle-Donne I, Rossi R, Colombo R et al. Biomarkers of oxidative damage in human disease. Clin Chem 2006; 52: 601-23.
10. Chandramathi S, Suresh K, Anita ZB et al. Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients. J Cancer Res Clin Oncol 2009; 135: 319-23.
11. Selmeci L, Seres L, Soós P et al. Kinetic assay for the determination of the oxidative stress biomarker, advanced oxidation protein products (AOPP) in the human blood plasma. Acta Physiol Hung 2008; 95: 209-18.
12. Kalousova M, Škrha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002; 51: 597-604.
13. Cakatay U. Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 2005; 31: 551-7.
14. Dursun E, Timur M, Dursun B et al. Protein oxidation in type 2 diabetic patients on hemodialysis. J Diabetes Complications 2005; 19: 142-6.
15. Shioji I. Oxidative stress related diseases and biopyrrins (in Japanese). Rinsho Byori 2005; 53: 155-9.
16. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney lnt 1996; 49: 1304-13.
17. Rice-Evans CA, Diploch AT, Symons MCR. Techniques in free radical research. Amsterdam: Elsevier, 1991.
18. Dalle-Donne I, Rossi R, Giustarini D et al. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003; 329: 23-38.
19. Cvetković T, Mitic B, Lazarević G et al. Oxidative stress parameters as possible urine markers in patients with diabetic nephropathy. J Diabetes Complications 2009; 23 (5): 337-52.
20. Schosinsky K, Vargas M, Esquinet A et al. Simple spectrometric determination of urinary albumin by dye-binding with bromophenol blue. Clin Chim Acta 1987; 33: 223-6.
21. Stadman ER, Levine RL. Protein oxidation. Ann N Y Acad Sci 2000; 899: 191-208.
22. Kalousová M, Zima T, Tesar V et al. Advanced glycoxidation end products in chronic diseases - clinical chemistry and genetic background. Mutat Res 2005; 579: 37-46.
23. Capeillere-Blandin C, Gausson V, Descapms-Latscha B et al. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 2004; 1689: 91-102.
24. Cakatay U, Kayali R, Uzun H. Relation of plasma protein oxidation parameters and a paraoxonase activity in the aging population. Clin Exp Med 2008; 8: 51-7.
25. Telci A, Cakatay U, Kayali R et al. Oxidative protein damage in plasma of type 2 diabetic patients. Horm Metab Res 2000; 32: 40-3.
26. Wittmann I, Wagner Z, Pótó L et al. Detection of carbonyl stress markers in the urine of diabetic patients (in Hungarian). Orv Hetil 1999; 140: 1841-5.
27. Gleisner A, Martinez L, Pino R et al. Oxidative stress markers in plasma and urine of prepubertal patients with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2006; 19: 995-1000.
28. Knapik-Kordecka M, Piwowar A, Warwas M. Oxidative-antioxidative balance disturbance and risk factors as well as vascular complications in patients with diabetes type 2 (in Polish). Wiad Lek 2007; 60: 329-34.
29. Piwowar A, Knapik-Kordecka M, Warwas M. AOPP and its relations with selected markers of oxidative/antioxidative system in type 2 diabetes mellitus. Diabetes Res Clin Pract 2007; 77: 188-92.
30. Iwao Y, Anraku M, Hiraike M et al. The structural and pharmacokinetic properties of oxidized human serum albumin, advanced oxidation protein products (AOPP). Drug Metab Pharmacokinet 2006; 21: 140-6.
31. Cvetković T, Vlahović P, Dordević V et al. The significance of urinary markers in the evaluation of diabetic nephropathy (in Serbian). J Med Biochem 2008; 27: 376-82.
32. Cirillo M, Laurenzi M, Mancini M et al. Low muscular mass and overestimation of microalbuminuria by urinary albumin/creatinine ratio. Hypertension 2006; 47: 56-61.
33. Piwowar A, Knapik-Kordecka M, Szczecifska J et al. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy. Diabetes Metab Res Rev 2008; 24: 549-53.
34. Asian M, Sabuncu T, Kocyigit A et al. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2007; 17: 734-40.
35. Shi XY, Hou FF, Niu HX et al. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 2008; 149: 1829-39.
36. Biswas SK, Peixoto EB, Souza DS et al. Hypertension increases pro-oxidant generation and decreases antioxidant defense in the kidney in early diabetes. Am J Nephrol 2008; 28: 133-42.